Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma Academic Article Article uri icon

Overview

MeSH Major

  • Precancerous Conditions
  • Prostatic Intraepithelial Neoplasia
  • Prostatic Neoplasms

abstract

  • Overexpression of cathepsin B and urokinase plasminogen activator can be used to identify those patients with chondrosarcoma of bone who have an increased risk of local recurrence and distant metastases.

publication date

  • September 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(20000901)89:5<995::AID-CNCR8>3.0.CO;2-8

PubMed ID

  • 10964329

Additional Document Info

start page

  • 995

end page

  • 1003

volume

  • 89

number

  • 5